Key result
Follicular phase is linked to ~6-point higher prevalence of elevated cholesterol versus the luteal phase.
Answers are grounded in this paper and cite their sources.
Biomarker assessment plays a critical role in the study and prevention of disease. However, variation in biomarkers attributable to the menstrual cycle in premenopausal women may impair understanding the role of certain biomarkers in disease development and progression. Thus, in light of the recently increasing evidence of menstrual cycle variability in multiple cardiometabolic biomarkers, a reexamination of approaches for appropriately studying and diagnosing cardiovascular disease in premenopausal women is warranted. We reviewed studies (from 1934 through 2012) evaluating changes in cardiometabolic biomarkers across phases of the menstrual cycle, including markers of oxidative stress, lipids, insulin sensitivity, and systemic inflammation. Each was observed to vary significantly during the menstrual cycle. For example, nearly twice as many women had elevated cholesterol levels warranting therapy (≥200 mg/dL) during the follicular phase compared with the luteal phase (14.3% vs. 7.9%), with only 3% having consistently high levels during all phases of the cycle. Similarly, nearly twice as many women were classified as being at an elevated risk of cardiovascular disease (high sensitivity C-reactive protein >3 mg/L) during menses compared with other phases (12.3% vs. 7.4%). Menstrual cycle-associated variability in cardiometabolic biomarkers is an important source of variability that should be accounted for in both research and clinical settings.
No takes yet. Share an insight, caveat, or question.
Schisterman et al. (2013) conducted a review in Elevated cardiometabolic biomarkers in premenopausal women. Menstrual cycle phase (follicular phase) vs. Luteal phase was evaluated on Elevated cholesterol levels (≥200 mg/dL). Menstrual cycle phases influence cardiometabolic biomarkers, with elevated cholesterol occurring in 14.3% of women during the follicular phase versus 7.9% in the luteal phase.
Synapse has enriched 10 related papers. Consider them for comparative context: